Integrated Proteins Limited has approved a 1-to-10 equity share split to reduce share costs and improve market liquidity. Concurrently, the Jamnagar-based company accepted several promoter reclassification requests and completed a major boardroom restructuring, replacing three resigning directors with new executive and independent appointments.
JAMNAGAR, India — Integrated Proteins Limited, a domestic agro-industrial and manufacturing enterprise, announced Thursday that its board of directors has formally approved a sub-division of its equity capital, splitting each individual share ten-fold. The comprehensive regulatory update, finalized at the company's registered office in Jamnagar, Gujarat, combines the structural stock split with a sweeping overhaul of the firm’s executive leadership and committee structures.
The development introduces immediate liquidity modifications for public market investors. By lowering the entry barrier for retail market participants, the corporate restructuring aligns with a broader operational push to diversify the company's public shareholding profile and streamline compliance under domestic securities guidelines.
Technical Mechanics of the Integrated Proteins Share Split
According to official corporate filings submitted to BSE Limited, the Board of Directors approved the sub-division of one existing equity share having a face value of ₹10 into 10 equity shares with a face value of ₹1 each. The equity shares post-split will remain fully paid-up.
The structural corporate restructuring requires an explicit amendment to the company’s foundational corporate charter. The board has authorized the alteration of Capital Clause V of the Memorandum of Association (MOA). Following necessary shareholder and statutory clearances, the altered authorized share capital of the company will be registered at ₹25,00,00,000, divided into 25,00,00,000 equity shares of ₹1 each. Prior to the subdivision, the authorized capital consisted of 2,50,00,000 shares at a face value of ₹10.
The pre-split issued, subscribed, and paid-up share capital stands at ₹18,71,36,000, represented by 1,87,13,600 equity shares. Post-split, this base will mathematically adjust to 18,71,36,000 individual equity shares at ₹1 each, subject to any incremental capital adjustments prior to the final execution date. Management stated that the expected time of completion for the total stock split process is tentatively placed within two months, pending general body meeting clearances.
Promoter Reclassification and Executive Leadership Overhaul
In a parallel corporate development, the board evaluated and approved formal applications from members of the existing promoter group seeking reclassification to the "Public" shareholder category under Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The outbound promoter block includes Vinod Prabhulal Mehta (holding 4,17,620 shares or 1.72 percent), Amrish Vinod Mehta (53,300 shares or 0.28 percent), Jyoti Vinodchandra Mehta (30,500 shares or 0.16 percent), and Piyush Chimanlal Vora (10,010 shares or 0.05 percent). Several other connected entities holding zero active equity shares were similarly cleared for public status reclassification, subject to final approval from BSE Limited.
Simultaneously, three primary corporate directors resigned from their governance posts at the close of business hours on July 9, 2026, all citing professional commitments and personal reasons. The departing executives include Independent Director Priyansh Tejas Parekh, Non-Executive Director Neepa Praful Kothari, and Executive Director Vinod Prabhulal Mehta.
To fill the vacancies, the company confirmed the following appointments effective July 9, 2026, each for a stipulated five-year tenure:
Mr. Nitesh Pratapray Mehta: Appointed as an Additional Director, categorized as an Executive Director.
Mr. Hiren Dhirajlal Shah: Appointed as an Additional Executive Director.
Mr. Sandeep Mahadik: Appointed as an Additional Non-Executive Independent Director, subject to upcoming shareholder voting.
Official Sources Section
The corporate updates were officially transmitted to financial regulators under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The compliance documentation was legally authorized and digitally signed by Shivangi Paliwal, Company Secretary and Compliance Officer of Integrated Proteins Limited, following the conclusion of the board session at 20:30 HRS IST.
Quote Section
In the official disclosure documentation submitted to the exchange, the company detailed the core strategic rationale behind the impending capital restructuring:
"The split of equity shares will make the shares more affordable and attractive to invest thereby encouraging greater participation of retail investors and will also enhance the liquidity of the Company's shares in the market."
Why It Matters
The structural capital split and leadership transformation present multi-layered implications for market participants:
For Retail Investors: The 1-to-10 stock split reduces the absolute nominal price per share unit in the open market, allowing smaller market participants to trade or accumulate the asset without allocating large blocks of capital.
For Corporate Governance: The departure of older promoter-backed directors and the induction of qualified professionals like Mr. Hiren Shah (holding LL.B. and BCA degrees) updates the administrative oversight of the public enterprise.
For Institutional Markets: The formal shift of 10 distinct promoter accounts into public tranches rebalances institutional holding metrics, which can impact public float and index tracking calculations over time.
Key Facts at a Glance
Subdivision Ratio: 1 equity share of ₹10 face value splits into 10 equity shares of ₹1 face value.
Timeline: The targeted completion window is tentatively fixed within 60 days from July 9, 2026.
Capital Ceiling: Authorized share capital remains anchored at ₹25 crore, adapted into 25 crore individual share units.
Committee Realignment: The company's Audit, Nomination, and Stakeholders Relationship committees have been fully reconstituted to match the new board roster.
Market Code: Integrated Proteins Limited trades actively under BSE Scrip Code 519606.
FAQ Section
When will the Integrated Proteins share split take effect?
The corporate board expects the process to conclude tentatively within two months from July 9, 2026. The exact Record Date will be declared to the stock exchange once the final approval from shareholders is secured.
Does the 1-to-10 share split change the total value of my investment?
No. While the total number of equity shares you hold will increase by a factor of 10, the nominal face value per share drops from ₹10 to ₹1, leaving the total aggregate value of your holdings unchanged at the time of execution.
Why are promoters shifting to the "Public" shareholder category?
Promoters filed for reclassification under SEBI Regulation 31A. This process permits outgoing management figures or minority promoter stakeholders to formally relinquish their promoter status, transferring their ownership into the standard public float.
Sources: Official regulatory board outcome disclosure filed by Integrated Proteins Limited to Stock Exchange
